• No results found

Preliminary Program CfDNA2015 Ver11

N/A
N/A
Protected

Academic year: 2021

Share "Preliminary Program CfDNA2015 Ver11"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

2nd International Meeting on Cell-Free DNA, cfDNA2015

Moltke’s Palace, Copenhagen, 28-29 May, 2015 – Preliminary Scientific Program, 6 March, 2015

cfDNA2015 Web: www.cfDNA2015.eu

DAY 1

8.00 – REGISTRATION

8.25 – OPENING by Frederik Banch Clausen 8.30 – INTRODUCTION

Obstetric and Immunological Background

Dr. Morten H Dziegiel (Copenhagen, Denmark)

The Genetics of Blood Groups – Recent Findings and Current Challenges

Professor Martin L Olsson (Lund, Sweden)

Noninvasive Typing of Fetal Antigens

Professor Ellen van der Schoot (Amsterdam, The Netherlands) 9.45 – Coffee Break

10.00 – FETAL RHD GENOTYPING I

Technical Aspects of Noninvasive

Fetal RHD Genotyping with Real-Time PCR

Professor Dr. Tobias J Legler (Göttingen, Germany)

Clinical Experience with First Trimester

Fetal RHD screening and Targeted Prophylaxis in Sweden

Dr. Eleonor Tiblad (Stockholm, Sweden) 10.55 – Coffee Break

11.10 – FETAL RHD GENOTYPING II

Noninvasive Fetal RHD Genotyping in England

Dr. Kirstin Finning (Bristol, England)

Clinical Perspectives from USA on Fetal RHD Genotyping

Professor Ossie Geifman-Holtzman (Philadelphia, USA) 12.00 – Lunch Break

13.00 – BIOLOGY AND IMMUNOLOGY

Cell-Free DNA – from the Placenta to the Immune System

Professor Dr. Sinuhe Hahn (Basel, Switzerland)

Microchimerism in Space and over Time: Our Interstellar Movie

Professor J Lee Nelson (Seattle, USA)

From Nine Usable Loci to Surveying the Genomic Landscape of Blood Cell Formation;

60 Years of Blood Cell Genomics

Professor Willem H Ouwehand (England) 14.30 – Coffee Break

15.00 – INTRODUCTION TO NIPT

New Developments in Noninvasive Prenatal Testing by Plasma DNA Sequencing

Professor Dennis Lo (Hong Kong, China) 16.00 – 17.00 POSTER SESSION

DAY 2

9.00 – NIPT FOR GENE DISORDERS AND CHROMOSOME ABNORMALITIES

Implementation of Cell-Free DNA Testing for Aneuploidy and Monogenic Disorders

Professor Lyn Chitty (London, UK)

Implementation of Whole Genome NIPT for Aneuploidies in Nijmegen

Dr. Brigitte Faas (Nijmegen, The Netherlands) 10.15 – Coffee Break

10.30 – NIPT SESSION CONTINUED

What Do Discordant NIPT Cases Teach Us About Perinatal Biology?

Professor Diana Bianchi (Boston, USA)

Microarray-Based Cell-Free DNA Analysis for Aneuploidy Risk Assessment

Dr. Thomas J Musci (San Francisco, USA) 11.45 – MAIN SPONSOR TALK

Illumina

12.00 – Lunch Break 13.00 – GENOME EDITING

Identifying Candidates for Genome Editing

Dr. Klaus Rieneck (Copenhagen, Denmark)

On Genome Editing

Dr. Andrew May (Berkeley, USA) 14.00 – Coffee Break

14.30 – FUTURE APPLICATIONS OF CELL-FREE DNA

Plasma DNA Sequencing in Cancer and Autoimmune Disease

Professor Dennis Lo (Hong Kong, China) 15.30 – ORAL PRESENTATIONS

A. The first year experiences of routine fetal RHD screening in Finland Katri Haimila (Finland)

B. Non-invasive prenatal testing of HPA*1A in Poland Agnieszka Orzinska (Poland)

C. Cell-free DNA analysis in maternal plasma for the detection of unbalanced chromosomal abnormalities other than main aneuploidies or microdeletionnel syndromes: a feasibilty study Pascale Kleinfinger (France)

D. Non-invasive prenatal diagnosis (NIPD) of Duchenne and Becker muscular dystrophies (DMD/BMD) by relative haplotype dosage Michael Parks (England)

E. Towards affordable NIPT - Low coverage whole genome resequencing based NIPT on small benchtop NGS systems Micheaela Hýblová (Slovakia)

F. Noninvasive prenatal detection of selected fetal aneuploidies using targeted sequencing of homologs Taylor Jensen (USA)

References

Related documents

Chapter 3 covers collision detection specifics, such as different ways to implement middle phase collision detection and an important theorem often used for collision detection

Senior Vice-President and Chief Economist of the World Bank Corruption, Food Security and the Foundations of Law and Economics | Paper |Presentation.. 10.15-12.15

[r]

Nevertheless, there remain open questions about the schemes’ behavior in under-resolved turbulent flows. It is not known which are the most accurate schemes in terms of

Again, although lithium (and GSK3β inhibition) decreased CRMP2-p-T514 in hiPSC-derived neurons from all patients (without altering CRMP2), abnormally high CRMP2-p-T514 levels in LiR

This study explored communication of support and cri- tique in virtual community threads about prenatal diag- noses of fetal anomalies and found that the majority of the support

Consistent findings that the components of Type D are related to depressive symptoms have led to suggestions that Type D and depressive symptoms are both facets of

Molecularly imprinted polymers with selectivity for oseltamivir shall be prepared in thin film formats on quartz crystal resonators;5. Resonators shall be used as quartz